DESMOID FIBROMATOSIS
Clinical trials for DESMOID FIBROMATOSIS explained in plain language.
Never miss a new study
Get alerted when new DESMOID FIBROMATOSIS trials appear
Sign up with your email to follow new studies for DESMOID FIBROMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis large national trial is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control over 50 different types of rare cancers that have few or no standard treatment options. It enrolled over 800 adults whose rare cancers had progressed …
Matched conditions: DESMOID FIBROMATOSIS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for kids with Tough-to-Treat tumors
Disease control OngoingThis study is testing an oral medication called nirogacestat in children and adolescents with desmoid tumors that are growing and cannot be removed by surgery. The main goals are to see if the drug can stop the tumors from progressing, to check how safe it is, and to understand h…
Matched conditions: DESMOID FIBROMATOSIS
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 02, 2026 15:24 UTC